Penumbra, Inc. Common Stock · Transaction Jul 10, 2025 · Filed Aug 13, 2025 · $1,001 to $15,000
NEW YORK STOCK EXCHANGE, INC. · PEN
-0.14% · -$0.4600 · Vol 240.9K
After hours · updated 16:18:52 ET
Penumbra Inc
Health Care
$317.54
Follow $PEN
One email when a member of Congress discloses a trade in it, with the official filing receipt linked.
Free. No account. Unsubscribe in one click.
Follow $PEN by emailVeridion Score
BETAHIGH CONF · 6 of 6 factors measuredFri Oct 2 · session closed · Markets closed · resumes Mon 9:30 ET · PEN
Methodologysnapshot unavailable for PEN. Cause unavailable.
PEN
Penumbra Inc
Fri Oct 2 · session closed · Markets closed · resumes Mon 9:30 ET
Lower range
Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
38/ 100
Veridion Score
Lower range · HIGH confidence · 6 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: HIGH · 6 of 6 factors measured · Fri Oct 2 · session closed · Markets closed · resumes Mon 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
SovereignWhy is PEN moving today?
Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Penumbra Inc
SURGICAL & MEDICAL INSTRUMENTS & APPARATUSListed since
2015
Employees
5K
Country
US
Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.
Key statistics
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Open
$318.37
Day high
$318.37
Day low
$316.78
Previous close
$318.00
52W high
$359.40
-11.65% from high
52W low
$225.54
69% of range
Market cap
$12.5B
P/E
78.99×
EPS
$4.02
Beta
0.04
Shares out
39.4M
Volume
240.9K
0.68× rel vol
Avg volume
353K
VWAP
$317.80
Price history computed in-house
1W
-0.42%
1M
-1.63%
3M
-0.32%
1Y
+25.27%
YTD
+2.13%
SMA 50 $321.62 · below
SMA 200 $326.83 · below
52W position 69%
PEN overview
Related filings and maps
Public disclosures
Congress activity in PEN
Official filing ↗
Federal contracts
PEN contract awards, year to date.
Public federal awards linked to this ticker.
Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for PEN in this window.
Lobbying spend
PEN lobbying filings, year to date.
Registered lobbying filings matched to Penumbra Inc.
Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for PEN in this window.
Analyst ratings
Sovereign unlock shows live analyst consensus for PEN.
Options
Options data is temporarily unavailable. Changing your plan will not restore the upstream feed.